Crystalline linagliptin intermediate and process for preparation of linagliptin
Abstract:
The present invention provides novel crystalline forms B1 & B2 of linagliptin intermediate of structural formula V and methods for production of novel crystalline form of linagliptin intermediate represented by the following structural formula V.
Information query
Patent Agency Ranking
0/0